Canada markets closed

Evofem Biosciences, Inc. (EVFM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0241-0.0019 (-7.31%)
At close: 03:56PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 258.60k
Enterprise Value 43.29M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.93
Price/Book (mrq)N/A
Enterprise Value/Revenue 3.19
Enterprise Value/EBITDA -1.68

Trading Information

Stock Price History

Beta (5Y Monthly) -1.20
52-Week Change 3-99.13%
S&P500 52-Week Change 327.86%
52 Week High 34.3750
52 Week Low 30.0120
50-Day Moving Average 30.0253
200-Day Moving Average 30.2063

Share Statistics

Avg Vol (3 month) 3820.55k
Avg Vol (10 day) 31.08M
Shares Outstanding 510.73M
Implied Shares Outstanding 610.73M
Float 810.73M
% Held by Insiders 10.01%
% Held by Institutions 10.96%
Shares Short (Jul 29, 2022) 469.46k
Short Ratio (Jul 29, 2022) 40.19
Short % of Float (Jul 29, 2022) 411.01%
Short % of Shares Outstanding (Jul 29, 2022) 410.98%
Shares Short (prior month Jun 30, 2022) 4142.57k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 18, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:125
Last Split Date 3May 18, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 344.82%
Operating Margin (ttm)-69.48%

Management Effectiveness

Return on Assets (ttm)-59.62%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)13.56M
Revenue Per Share (ttm)6.40
Quarterly Revenue Growth (yoy)-19.80%
Gross Profit (ttm)N/A
EBITDA -25.81M
Net Income Avi to Common (ttm)43.61M
Diluted EPS (ttm)38.9700
Quarterly Earnings Growth (yoy)-26.30%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)41.23M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.17
Book Value Per Share (mrq)-9.92

Cash Flow Statement

Operating Cash Flow (ttm)-15.33M
Levered Free Cash Flow (ttm)-13.48M